Rhumbline Advisers Seelos Therapeutics, Inc. Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.51 - $0.93 $30,579 - $55,762	-59,960 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.84 - $1.71 $2,339 - $4,762	2,785 Added 4.87%	59,960 $50,000
Q4 2021 Feb 10, 2022	BUY	$1.59 - $2.38 $2,730 - $4,086	1,717 Added 3.1%	57,175 $93,000
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $6,077 - $10,392	3,596 Added 6.93%	55,458 $134,000
Q2 2021 Aug 05, 2021	BUY	$2.64 - $6.32 $136,915 - $327,767	51,862 New	51,862 $137,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.